netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Alternative Treatment for Diabetic Retinopathy

A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that damages blood vessels in the light-sensitive retina in the back of the eye. Lucentis is used to treat wet macular degeneration as well as diabetic macula edema. The study found the treatment no less effective than the laser therapy which currently is the standard treatment for PDR.

Read the press release.

Read the study.

In a RPB-supported commentary, Timothy W. Olsen, MD, notes that "this important study [...] represents a major step forward for patients with PDR by providing the ophthalmologists who manage their retinal disease with new options." But he adds a cautionary note. 

Read the commentary.

 

Related News: Diabetic Retinopathy, Top Story

RPB and AAO Announce New Grant Opportunities to Support Vision Research

Partnership to utilize IRIS Registry database to advance patient care.

Read More

 

Reversing Retinal Degenerative Diseases: We’re One Step Closer

RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.

Read More

 

Understanding Usher Syndrome: New Findings

RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.

Read More

 

New Stem Cell Model Replicates Macular Degeneration

The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.

Read More

 

Researchers ID Key Compounds Related to Blood Vessel Growth in Wet AMD

The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world

Read More

 

FAQs: Aug. 21 Solar Eclipse

RPB provides information to help you protect your eyes during the upcoming solar eclipse.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.